Globe Textile Mills owners sue OBS to terminate merger agreement

In a significant development within Pakistan's corporate landscape, the majority shareholders of Globe Textile Mills Limited (PSX: GLOT) have initiated legal proceedings against OBS Pakistan, seeking to annul a previously agreed-upon acquisition deal. The lawsuit, filed in the Sindh High Court, alleges that OBS failed to fulfill certain undisclosed obligations stipulated in the merger agreement, prompting Globe Textile's owners to pursue termination of the contract.

The acquisition, initially announced in early 2024, was poised to mark OBS Pakistan's entry into the textile sector, diversifying its portfolio beyond pharmaceuticals. However, sources close to the matter indicate that OBS's inability to meet specific financial and operational commitments has led to the current legal impasse.

OBS Pakistan operates as a prominent entity within the nation's pharmaceutical industry. Established in 1963, the company has evolved into a key player, offering a range of healthcare products and services. OBS Pakistan functions under the umbrella of the OBS Group, a conglomerate with a significant presence in both Pakistan and Sri Lanka. The group is known for its strategic alliances with international pharmaceutical giants, including Merck & Co. Inc., Organon, and Schering-Plough.

The OBS Group's operations are diversified across several subsidiaries, such as AGP Limited and Aspin Pharma, each focusing on different segments of the healthcare market. AGP Limited, for instance, has been instrumental in marketing products from global partners like Mylan (USA) and Santen (Japan) within Pakistan. These collaborations have bolstered OBS's reputation as a reliable partner in the pharmaceutical sector.